San Francisco, CA, United States of America

Marie-Cecile Van De Lavoir

This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Crystal Bioscience Inc., Origen Therapeutics, Inc.. Active years: 2006-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marie-Cecile Van De Lavoir. Retrieved from https://idiyas.com/inventor/marie-cecile-van-de-lavoir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

 

Average Co-Inventor Count = 2.6

ph-index = 1

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Marie-Cecile Van De Lavoir

Introduction

Marie-Cecile Van De Lavoir is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of avian biology, particularly in the area of culturing avian gonocytes. With a total of three patents to her name, her work has the potential to impact therapeutic protein production.

Latest Patents

Marie-Cecile's latest patents include a method for culturing avian gonocytes. This patent provides a sustained culture of isolated avian gonocytes, along with a method for making and using these cells. Additionally, it describes a chimeric avian containing an isolated gonocyte and a transgenic avian produced using this chimeric avian. The methods and cells developed may be employed to create transgenic avians that produce heterologous proteins, such as therapeutic proteins.

Career Highlights

Throughout her career, Marie-Cecile has worked with notable companies, including Crystal Bioscience Inc. and Origen Therapeutics, Inc. Her innovative research has positioned her as a key figure in her field, contributing to advancements in genetic engineering and biotechnology.

Collaborations

Marie-Cecile has collaborated with esteemed colleagues, including Robert Etches and Babette Heyer. These partnerships have further enhanced her research and development efforts in avian biology.

Conclusion

Marie-Cecile Van De Lavoir's work exemplifies the intersection of innovation and biotechnology. Her contributions to the culturing of avian gonocytes are paving the way for future advancements in the production of therapeutic proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…